Endogenous brain protection by granulocyte-colony stimulating factor after ischemic stroke

Area of Science:

• Neuroscience
• Hematology
• Immunology

Background:

• Granulocyte-colony stimulating factor (G-CSF) shows promise in experimental stroke models.
• A clear understanding of G-CSF's role in stroke recovery, particularly in its absence, is lacking.
• Matrix metalloproteinase 9 (MMP-9) is implicated in stroke pathology.

Purpose of the Study:

• To investigate the impact of G-CSF deficiency on stroke outcomes, including infarct volume and functional recovery.
• To examine the role of G-CSF in regulating MMP-9 expression post-stroke.
• To evaluate the therapeutic potential of G-CSF substitution in G-CSF deficient mice.

Main Methods:

• Experimental stroke induced in wildtype, G-CSF deficient, and G-CSF substituted G-CSF deficient mice.
• Assessment of infarct volumes, neurological deficits, and sensorimotor function.
• Immunohistochemistry and real-time PCR to analyze peri-ischemic MMP-9 mRNA and protein expression.

Main Results:

• G-CSF deficient mice exhibited significantly larger infarct volumes and poorer functional recovery compared to wildtype mice.
• G-CSF substitution in deficient mice led to reduced lesion size and improved neurological and sensorimotor function.
• G-CSF deficiency was associated with increased MMP-9 expression, which was suppressed by G-CSF treatment.

Conclusions:

• Endogenous G-CSF is essential for brain recovery mechanisms following stroke.
• G-CSF deficiency exacerbates stroke-induced brain damage and functional deficits.
• G-CSF substitution therapy is effective in mitigating stroke severity and promoting recovery, partly through MMP-9 regulation.